HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yun Yu Selected Research

Colonic Neoplasms (Colon Cancer)

10/2023Regorafenib activates oxidative stress by inhibiting SELENOS and potentiates oxaliplatin-induced cell death in colon cancer cells.
4/2022Dihydroartemisinin enhances the anti-tumor activity of oxaliplatin in colorectal cancer cells by altering PRDX2-reactive oxygen species-mediated multiple signaling pathways.
11/2019Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer.
11/2016Downregulation of AIF by HIF-1 contributes to hypoxia-induced epithelial-mesenchymal transition of colon cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yun Yu Research Topics

Disease

50Neoplasms (Cancer)
05/2024 - 01/2005
9Inflammation (Inflammations)
05/2024 - 01/2020
8Breast Neoplasms (Breast Cancer)
12/2021 - 12/2013
7Acute Promyelocytic Leukemia
11/2007 - 02/2002
6Leukemia
01/2023 - 02/2002
6Schizophrenia (Dementia Praecox)
01/2022 - 01/2014
6Hypoxia (Hypoxemia)
10/2020 - 07/2005
5Arthritis (Polyarthritis)
11/2023 - 06/2019
5Type 2 Diabetes Mellitus (MODY)
04/2023 - 03/2012
5Neoplasm Metastasis (Metastasis)
05/2021 - 11/2015
4Liver Neoplasms (Liver Cancer)
05/2024 - 12/2018
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 01/2020
4Colonic Neoplasms (Colon Cancer)
10/2023 - 11/2016
4Wounds and Injuries (Trauma)
01/2023 - 05/2002
4Hyperuricemia
01/2023 - 01/2020
4Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 08/2014
4Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
05/2021 - 04/2014
3Sepsis (Septicemia)
01/2024 - 01/2016
3Experimental Arthritis
12/2023 - 06/2020
3Lung Neoplasms (Lung Cancer)
11/2023 - 01/2020
3Traumatic Brain Injuries (Traumatic Brain Injury)
06/2023 - 04/2015
3Cognitive Dysfunction
01/2023 - 01/2021
3Prostatic Neoplasms (Prostate Cancer)
12/2022 - 01/2014
3Insulin Resistance
08/2022 - 03/2020
3Hemorrhage
01/2022 - 01/2021
3Necrosis
01/2022 - 06/2019
3Stomach Neoplasms (Stomach Cancer)
01/2020 - 03/2015
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2008 - 05/2005
2Gouty Arthritis
01/2024 - 04/2021
2Cholestasis
11/2023 - 01/2016
2Ischemic Stroke
07/2023 - 01/2021
2Stroke (Strokes)
07/2023 - 01/2021
2Bronchiolitis Obliterans Syndrome
01/2023 - 01/2021
2Obesity
12/2022 - 01/2021
2Hyperglycemia
08/2022 - 11/2020
2Ulcerative Colitis
06/2022 - 01/2022

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
05/2024 - 07/2005
7Interleukin-6 (Interleukin 6)IBA
11/2023 - 06/2013
6Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2005
6Reactive Oxygen Species (Oxygen Radicals)IBA
10/2023 - 01/2016
6Phosphotransferases (Kinase)IBA
01/2023 - 05/2005
6SilverIBA
10/2022 - 10/2011
6CytokinesIBA
01/2021 - 01/2017
6Arsenic Trioxide (Trisenox)FDA Link
09/2007 - 02/2002
5AntioxidantsIBA
01/2024 - 07/2005
5Uric Acid (Urate)IBA
01/2024 - 01/2021
5Therapeutic UsesIBA
01/2024 - 11/2020
5BerberineIBA
12/2023 - 06/2019
5MicroRNAs (MicroRNA)IBA
11/2023 - 10/2019
5Glucose (Dextrose)FDA LinkGeneric
01/2023 - 03/2020
5Durapatite (Hydroxylapatite)IBA
08/2022 - 01/2020
5AlbuminsIBA
08/2022 - 08/2014
4Oxygen (Dioxygen)IBA
03/2024 - 01/2017
4JNK Mitogen-Activated Protein KinasesIBA
10/2023 - 01/2021
4Urate Oxidase (Uricase)IBA
01/2023 - 01/2020
4Serum AlbuminIBA
08/2022 - 01/2020
4Messenger RNA (mRNA)IBA
01/2022 - 12/2005
4LipidsIBA
01/2022 - 08/2015
4Blood Proteins (Serum Proteins)IBA
12/2021 - 08/2014
4NSC606985IBA
06/2009 - 05/2005
4CamptothecinIBA
06/2009 - 05/2005
3RNA (Ribonucleic Acid)IBA
05/2024 - 01/2018
3STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2023 - 01/2020
3PorphyrinsIBA
11/2023 - 01/2021
3Propofol (Diprivan)FDA LinkGeneric
06/2023 - 04/2015
3Indicators and Reagents (Reagents)IBA
01/2023 - 11/2021
3Cisplatin (Platino)FDA LinkGeneric
01/2023 - 06/2009
3CateninsIBA
01/2022 - 11/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2021 - 11/2018
3Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2021 - 11/2018
3Trichloroethylene (Trichloroethene)IBA
01/2020 - 07/2018
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2018 - 11/2015
3Apoptosis Inducing FactorIBA
11/2016 - 03/2015
3EnzymesIBA
01/2016 - 06/2009
3Tretinoin (Retinoic Acid)FDA LinkGeneric
09/2007 - 02/2002
2MatrinesIBA
01/2024 - 10/2023
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2024 - 06/2022
2Hematoxylin (Haematoxylon)IBA
01/2024 - 09/2014
2Eosine Yellowish-(YS) (Eosin)IBA
01/2024 - 09/2014
2simiaowanIBA
01/2024 - 04/2021
2AntigensIBA
11/2023 - 11/2023
2phthalic acid (phthalate)IBA
11/2023 - 09/2022
2AMP-Activated Protein KinasesIBA
11/2023 - 10/2020
2Metal-Organic FrameworksIBA
11/2023 - 01/2021
2Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2023 - 04/2022
2regorafenibIBA
10/2023 - 01/2023
2Triglycerides (Triacylglycerol)IBA
01/2023 - 01/2023
2PolymersIBA
01/2023 - 01/2022
2RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2023 - 01/2020
2Complement System Proteins (Complement)IBA
01/2023 - 04/2014
2Colloids (Colloid)IBA
08/2022 - 01/2020
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
08/2022 - 03/2012
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
01/2022 - 09/2019
2Tranexamic Acid (AMCA)FDA Link
01/2022 - 11/2021
2LipopolysaccharidesIBA
01/2022 - 12/2021

Therapy/Procedure

17Therapeutics
01/2024 - 09/2007
5Drug Therapy (Chemotherapy)
01/2023 - 06/2009
3Artificial Respiration (Mechanical Ventilation)
01/2024 - 01/2016
2Immunotherapy
11/2023 - 11/2023
2Intraperitoneal Injections
01/2022 - 03/2020